KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Castle Biosciences (CSTL) Leases (2021 - 2025)

Historic Leases for Castle Biosciences (CSTL) over the last 5 years, with Q3 2025 value amounting to $15.2 million.

  • Castle Biosciences' Leases rose 2727.65% to $15.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.2 million, marking a year-over-year increase of 2727.65%. This contributed to the annual value of $11.6 million for FY2024, which is 586.71% down from last year.
  • As of Q3 2025, Castle Biosciences' Leases stood at $15.2 million, which was up 2727.65% from $15.5 million recorded in Q2 2025.
  • Castle Biosciences' 5-year Leases high stood at $15.5 million for Q2 2025, and its period low was $7.0 million during Q2 2022.
  • Over the past 5 years, Castle Biosciences' median Leases value was $11.6 million (recorded in 2023), while the average stood at $11.4 million.
  • In the last 5 years, Castle Biosciences' Leases skyrocketed by 6498.71% in 2022 and then plummeted by 786.26% in 2023.
  • Castle Biosciences' Leases (Quarter) stood at $7.4 million in 2021, then soared by 64.99% to $12.2 million in 2022, then rose by 1.03% to $12.3 million in 2023, then dropped by 5.87% to $11.6 million in 2024, then surged by 30.79% to $15.2 million in 2025.
  • Its last three reported values are $15.2 million in Q3 2025, $15.5 million for Q2 2025, and $11.2 million during Q1 2025.